HYBRIGENICS
LIVE

Serial Number

77021985

Owner

HYBRIGENICS SA

Attorney

Jeannine A Rittenhouse

Filing Date

Oct 16, 2006

Add to watchlist:

No watchlists yet
View on USPTO

HYBRIGENICS Trademark

Serial Number: 77021985 • Registration: 3559448

HYBRIGENICS is a trademark filed by HYBRIGENICS SA on October 16, 2006. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HYBRIGENICS SA (12 trademarks)

3/5 Impasse Reille

Entity Type: 99

Trademark Details

Filing Date

October 16, 2006

Registration Date

January 13, 2009

Published for Opposition

October 28, 2008

Goods & Services

[ Computer programs for scientific analysis of genetic sequences; software and software packages, namely, drug, chemical and protein screening software, software for interpretation of neuro and brain scans provided by diagnostic imaging equipment; interface boards for computers, apparatus for recording, transmission and reproduction of sound and images; data processing equipment in the nature of data processors and computers, all the aforesaid goods being used in biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy ]

[ Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system, the cardiovascular system, the metabolic system, genito-urinary system, the musculo-skeletal system, dermatologic system, alimentary tract, sensory organs, and parasitic diseases; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation and for gastroenterological disorders; chemico-pharmaceutical preparations used in the treatment of viral and infections diseases, cancer, neurodegenerative diseases, obesity and diabetes; pharmaceutical preparations used in the treatment of viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; antibiotics, biological, biochemical and biotechnological preparations for medical purposes, chemical preparations for pharmaceutical purposes for the treatment of neurological, inflammatory, immunological, dermatological, viral and infectious diseases, infections, parasites, cancer, neurodegenerative diseases, obesity and diabetes; reagents in the nature of microorganism cultures for medical use; surgical tissues, namely, surgical implants comprising living tissue; radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; therapeutic proteins for use in the treatment of cancer ]

[ Telecommunications, namely, transmission of information via computer transmission, digital networks, electronic communications network and the telecommunication network; communications by computer terminals in the nature of communications via analogue and digital computer terminals and by satellite; transmission of information, namely, via computer networks; communications and exchanges of information on a telecommunications network; computer aided transmission of images, data, and messages; providing multiple use access to global computer information networks for the dissemination of data; providing access to databases by means of computer servers; communication by hypertext links on a telecommunications network; transmission of database information via telecommunications networks; electronic mail services; electronic transmission of data in electronic directories and electronic transmission of information for and by a telecommunications network, all the aforesaid services being used in biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy ]

[ Subscription services to databases in the nature of subscription to electronic journals; database management; all the aforesaid services being used in biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy ]

[ Biological materials, namely, biological reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biological tissue, namely, blood and stem cells, for scientific and medical research use; cells for scientific, laboratory or medical research; proteins, namely, protein arrays and nucleotide arrays for scientific and medical research, and therapeutic proteins for scientific use in the following: drug discovery, genomic sequences, DNA, enzyme, toxin, bacteria, virus and microbes ]

Scientific and industrial research, engineering services in the nature of development of industrial processes, consulting services in the field of office and workplace automation, product development, professional consultancy, material testing, chemical and medical laboratories, computer programming, all the aforesaid services being used in biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy; scientific and industrial research in the field of molecular biology, namely, genomic, proteomic, protein screening and research of protein interaction, and genetic mapping for scientific purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Dec 23, 2019 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 23, 2019 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Dec 23, 2019 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Dec 23, 2019 8PRT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 10, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 10, 2019 REAP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Dec 10, 2019 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Jul 16, 2019 PR89
TEAS SECTION 8 & 9 RECEIVED
Jul 12, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 13, 2018 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Aug 12, 2015 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Aug 12, 2015 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 12, 2015 APRE
TEAS SECTION 8 RECEIVED
Jul 13, 2015 ES8R
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2009 R.PR
PUBLISHED FOR OPPOSITION
Oct 28, 2008 PUBO
NOTICE OF PUBLICATION
Oct 8, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 23, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 23, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 23, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 23, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 23, 2008 CNEA
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Sep 22, 2008 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Sep 22, 2008 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Sep 22, 2008 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2008 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2008 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2008 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 10, 2008 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 17, 2008 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 7, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
May 7, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 7, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
May 7, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 7, 2008 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 5, 2008 GNFN
FINAL REFUSAL E-MAILED
May 5, 2008 GNFR
FINAL REFUSAL WRITTEN
May 5, 2008 CNFR
DATA MODIFICATION COMPLETED
May 5, 2008 DMCC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 1, 2008 RCSC
ASSIGNED TO LIE
Apr 1, 2008 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2008 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 21, 2008 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 21, 2007 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 21, 2007 GNSL
SUSPENSION LETTER WRITTEN
Sep 21, 2007 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2007 TROA
NON-FINAL ACTION E-MAILED
Mar 5, 2007 GNRT
NON-FINAL ACTION WRITTEN
Mar 5, 2007 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2007 DOCK
NEW APPLICATION ENTERED
Oct 19, 2006 NWAP